Elements of House User Fee Draft Would Slow Drug Reviews: Woodcock

Washington Drug Letter
CDER Director Janet Woodcock is urging House lawmakers not to overload their omnibus user fee draft with unfunded mandates that would add unneeded “work strain” to the resource-strapped FDA, including a requirement that would expedite manufacturing changes to speed shortage drugs to market.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00